<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02344342</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00091053</org_study_id>
    <nct_id>NCT02344342</nct_id>
  </id_info>
  <brief_title>University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project</brief_title>
  <acronym>Manifold-HF</acronym>
  <official_title>Michigan Advanced Heart Failure TelemoNItoring and FLexible Diuretic Trial - MANIFOLD-HF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed project is a 2x2 factorial designed study aimed at assessing the impact of 1) a
      home tele-monitoring system and 2) a flexible diuretic regimen among high risk heart failure
      patients in the University of Michigan Health System (UMHS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed project is a 2x2 factorial designed study aimed at assessing the impact of 1) a
      home tele-monitoring system and 2) a flexible diuretic regimen among high risk heart failure
      patients in the University of Michigan Health System (UMHS). The first intervention consists
      of the use of a home monitoring tool utilizing a tablet interface. The device facilitates
      collection of heart failure patient self-care information, including weight, blood pressure,
      heart rate and heart failure symptoms. This information is collected and stored on a secured
      server provided by the vendor, and can be viewed by the physician and nursing team. The
      second intervention is a flexible diuretic regimen strategy. This intervention will be
      applied in an independent randomized fashion. The flexible regimen will be prescribed by the
      patient's physician. The two interventions will be applied to heart failure patients treated
      at the University of Michigan. A total of 400 patients will be enrolled into the study.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The industry sponsor has discontinued the product under evaluation in the study.
  </why_stopped>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Days Hospitalized or Dead in the 180 Day Follow up Period</measure>
    <time_frame>180 days (6 months)</time_frame>
    <description>This is the total combined number of days that all participants in each arm were hospitalized or dead between day 1 and day 180. It is a method to combine the endpoints of death and hospitalization used in heart failure trials. Days hospitalized for all participants are added to days dead for all participants, per arm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self Care for Heart Failure Index Score</measure>
    <time_frame>180 day follow up</time_frame>
    <description>The self care for heart failure index score ranges from 22 to 88 where 22 is the lowest score meaning cares for oneself least well and 88 means one is most confident or able to care for oneself properly.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living With Heart Failure Questionnaire</measure>
    <time_frame>180 day follow up</time_frame>
    <description>It provides a total score (range 0-105, where 0 is best quality of life up to 105 as worst Health Related Quality of Life),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to Hospitalization or Death (if it Occurs Within 180 Days)</measure>
    <time_frame>180 days</time_frame>
    <description>Time to Hospitalization (if participant was hospitalized and did not die) or death whichever came first. In fact all participants who died in the follow up period were hospitalized first, so actual data reported below also represents time to hospitalization for all participants.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Health Buddy Web Management system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the telemonitoring intervention will be assigned to use the Bosch Health Buddy Web management system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flexible Diuretic Regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized into the Flexible Diuretic Regimen intervention will have a diuretic regimen specified by specific weight ranges.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemonitoring</intervention_name>
    <description>The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.</description>
    <arm_group_label>Health Buddy Web Management system</arm_group_label>
    <arm_group_label>Flexible Diuretic Regimen</arm_group_label>
    <other_name>Bosch Health Buddy Web Management System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flexible Diuretic Regimen</intervention_name>
    <description>Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
    <arm_group_label>Health Buddy Web Management system</arm_group_label>
    <arm_group_label>Flexible Diuretic Regimen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. University of Michigan patients hospitalized for the treatment of heart failure,
             within the past 30 days.

          2. Patients must be receiving an oral loop diuretic on their home regimen or have
             received intravenous loop diuretic during the index hospitalization at the time of
             enrollment.

          3. Patients must have an assessment of left ventricular function within the previous 2
             years.

          4. Patients must have LVEF ≤ 40%, or LVEF &gt;40 with evidence of left atrial enlargement
             (LA dimension &gt; 40 mm), BNP &gt; 200 ng/ml or PCW &gt; 18 mmHg.

        Exclusion Criteria:

          -  Prisoners

          -  Residents of long term nursing facilities

          -  Enrollment into a hospice program

          -  Receiving dialysis

          -  Patients with dementia

          -  Patients with dGFR less than 20ml/min.

          -  Patients being worked up for heart surgery.

          -  Patients being worked up for heart transplant.

          -  Patients being evaluated for revascularization.

          -  Patients being evaluated for heart valve intervention.

          -  Patients with primary pulmonary hypertension.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd M Koelling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2015</study_first_submitted>
  <study_first_submitted_qc>January 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <results_first_submitted>October 4, 2016</results_first_submitted>
  <results_first_submitted_qc>March 21, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 2, 2017</results_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Todd M Koelling, MD</investigator_full_name>
    <investigator_title>Professor of Internal Medicine, Director of Heart Failure Program</investigator_title>
  </responsible_party>
  <keyword>telemonitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diuretics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were randomized to one of 4 study groups:
Telemedicine intervention_YES and Flexible Diuretic_YES Telemedicine intervention_YES and Flexible Diuretic_NO Telemedicine intervention_NO and Flexible Diuretic_YES Telemedicine intervention_NO and Flexible Diuretic_NO</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Health Buddy Yes and Flexible Diuretic Yes</title>
          <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
        </group>
        <group group_id="P2">
          <title>Health Buddy Yes and Flexible Diuretic Regimen No</title>
          <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: These patients will not be assigned to receive a flexible diuretic prescription</description>
        </group>
        <group group_id="P3">
          <title>Health Buddy No and Flexible Diuretic Yes</title>
          <description>Telemonitoring: These patients will not receive care with the Health Buddy Web intervention.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
        </group>
        <group group_id="P4">
          <title>Health Buddy No and Flexible Diuretic No</title>
          <description>Telemonitoring: These patients will not be assigned to the Health Buddy Web intervention.
Flexible Diuretic Regimen: These patients will not be assigned to follow a flexible diuretic regimen.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Industry partner dropped out</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Group Number of subjects TM_YES_AND_FD_YES 13 TM_YES_AND_FD_NO 11 TM_NO_AND_FD_YES 14 TM_NO_AND_FD_NO 13</population>
      <group_list>
        <group group_id="B1">
          <title>Health Buddy Yes and Flexible Diuretic Yes</title>
          <description>Telemonitoring: Yes
Flexible Diuretic Yes</description>
        </group>
        <group group_id="B2">
          <title>Health Buddy Yes and Flexible Diuretic No</title>
          <description>Telemonitoring: Yes
Flexible Diuretic No</description>
        </group>
        <group group_id="B3">
          <title>Health Buddy No and Flexible Diuretic Yes</title>
          <description>Telemonitoring: No
Flexible Diuretic Yes</description>
        </group>
        <group group_id="B4">
          <title>Health Buddy No and Flexible Diuretic No</title>
          <description>Telemonitoring: No
Flexible Diuretic No</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="14"/>
            <count group_id="B4" value="13"/>
            <count group_id="B5" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Days Hospitalized or Dead in the 180 Day Follow up Period</title>
        <description>This is the total combined number of days that all participants in each arm were hospitalized or dead between day 1 and day 180. It is a method to combine the endpoints of death and hospitalization used in heart failure trials. Days hospitalized for all participants are added to days dead for all participants, per arm.</description>
        <time_frame>180 days (6 months)</time_frame>
        <population>The subjects included in this measure each completed the 180 follow up period or died within the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Health Buddy Yes and Flexible Diuretic Yes</title>
            <description>Telemonitoring: Yes
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O2">
            <title>Health Buddy Yes and Flexible Diuretic No</title>
            <description>Telemonitoring: Yes
Flexible Diuretic No</description>
          </group>
          <group group_id="O3">
            <title>Health Buddy No and Flexible Diuretic Yes</title>
            <description>Telemonitoring: No
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O4">
            <title>Health Buddy No and Flexible Diuretic No</title>
            <description>Telemonitoring: No
Flexible Diuretic No</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days Hospitalized or Dead in the 180 Day Follow up Period</title>
          <description>This is the total combined number of days that all participants in each arm were hospitalized or dead between day 1 and day 180. It is a method to combine the endpoints of death and hospitalization used in heart failure trials. Days hospitalized for all participants are added to days dead for all participants, per arm.</description>
          <population>The subjects included in this measure each completed the 180 follow up period or died within the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
          <units>Days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Self Care for Heart Failure Index Score</title>
        <description>The self care for heart failure index score ranges from 22 to 88 where 22 is the lowest score meaning cares for oneself least well and 88 means one is most confident or able to care for oneself properly.</description>
        <time_frame>180 day follow up</time_frame>
        <population>Two participants completed the study but did not answer all of the questions on this questionnaire, and therefore they are not included in the report for this secondary end point. The subjects included completed the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Health Buddy Yes and Flexible Diuretic Yes</title>
            <description>Telemonitoring: Yes
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O2">
            <title>Health Buddy Yes and Flexible Diuretic No</title>
            <description>Telemonitoring: Yes
Flexible Diuretic No</description>
          </group>
          <group group_id="O3">
            <title>Health Buddy No and Flexible Diuretic Yes</title>
            <description>Telemonitoring: No
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O4">
            <title>Health Buddy No and Flexible Diuretic No</title>
            <description>Telemonitoring: No
Flexible Diuretic No</description>
          </group>
        </group_list>
        <measure>
          <title>Self Care for Heart Failure Index Score</title>
          <description>The self care for heart failure index score ranges from 22 to 88 where 22 is the lowest score meaning cares for oneself least well and 88 means one is most confident or able to care for oneself properly.</description>
          <population>Two participants completed the study but did not answer all of the questions on this questionnaire, and therefore they are not included in the report for this secondary end point. The subjects included completed the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83">For a single participant, there is no range beyond the value of that individual.</measurement>
                    <measurement group_id="O2" value="71" lower_limit="59" upper_limit="84"/>
                    <measurement group_id="O4" value="80" lower_limit="78" upper_limit="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Minnesota Living With Heart Failure Questionnaire</title>
        <description>It provides a total score (range 0–105, where 0 is best quality of life up to 105 as worst Health Related Quality of Life),</description>
        <time_frame>180 day follow up</time_frame>
        <population>2 patients completed the study, whose answers were not coded into the analysis for the questionnaire, therefore they are not included in the report for this secondary end point. The subjects included completed the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Health Buddy Yes and Flexible Diuretic Yes</title>
            <description>Telemonitoring: Yes
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O2">
            <title>Health Buddy Yes and Flexible Diuretic No</title>
            <description>Telemonitoring: Yes
Flexible Diuretic No</description>
          </group>
          <group group_id="O3">
            <title>Health Buddy No and Flexible Diuretic Yes</title>
            <description>Telemonitoring: No
Flexible Diuretic Yes</description>
          </group>
          <group group_id="O4">
            <title>Health Buddy No and Flexible Diuretic No</title>
            <description>Telemonitoring: No
Flexible Diuretic No</description>
          </group>
        </group_list>
        <measure>
          <title>Minnesota Living With Heart Failure Questionnaire</title>
          <description>It provides a total score (range 0–105, where 0 is best quality of life up to 105 as worst Health Related Quality of Life),</description>
          <population>2 patients completed the study, whose answers were not coded into the analysis for the questionnaire, therefore they are not included in the report for this secondary end point. The subjects included completed the 180 follow up period. Subjects that had less than 180 days of follow up at the time of study closure are excluded from this analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49">Because there is only a single participant's data presented, there is no range beyond that individual's data.</measurement>
                    <measurement group_id="O2" value="22" lower_limit="15" upper_limit="29"/>
                    <measurement group_id="O4" value="74" lower_limit="62" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days to Hospitalization or Death (if it Occurs Within 180 Days)</title>
        <description>Time to Hospitalization (if participant was hospitalized and did not die) or death whichever came first. In fact all participants who died in the follow up period were hospitalized first, so actual data reported below also represents time to hospitalization for all participants.</description>
        <time_frame>180 days</time_frame>
        <population>All participants who completed 180 days or died prior to 180 days (all who completed study and all listed in all cause mortality)</population>
        <group_list>
          <group group_id="O1">
            <title>Health Buddy Yes and Flexible Diuretic Yes</title>
            <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
          </group>
          <group group_id="O2">
            <title>Health Buddy Yes and Flexible Diuretic Regimen No</title>
            <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: These patients will not be assigned to receive a flexible diuretic prescription</description>
          </group>
          <group group_id="O3">
            <title>Health Buddy No and Flexible Diuretic Yes</title>
            <description>Telemonitoring: These patients will not receive care with the Health Buddy Web intervention.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
          </group>
          <group group_id="O4">
            <title>Health Buddy No and Flexible Diuretic No</title>
            <description>Telemonitoring: These patients will not be assigned to the Health Buddy Web intervention.
Flexible Diuretic Regimen: These patients will not be assigned to follow a flexible diuretic regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Days to Hospitalization or Death (if it Occurs Within 180 Days)</title>
          <description>Time to Hospitalization (if participant was hospitalized and did not die) or death whichever came first. In fact all participants who died in the follow up period were hospitalized first, so actual data reported below also represents time to hospitalization for all participants.</description>
          <population>All participants who completed 180 days or died prior to 180 days (all who completed study and all listed in all cause mortality)</population>
          <units>days till hospitalization</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" lower_limit="62" upper_limit="152"/>
                    <measurement group_id="O2" value="155" lower_limit="114" upper_limit="195"/>
                    <measurement group_id="O3" value="102" lower_limit="70" upper_limit="134"/>
                    <measurement group_id="O4" value="122" lower_limit="83" upper_limit="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>180 days (or 6 months) from discharge date or from the day patient started using the intervention.</time_frame>
      <desc>Subjects were expected to start the intervention on the day of discharge from the hospital, but some subjects once they returned home.</desc>
      <group_list>
        <group group_id="E1">
          <title>Health Buddy Web YES/Flexible Diuretic YES</title>
          <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
        </group>
        <group group_id="E2">
          <title>Health Buddy Web YES /Flexible Diuretic NO</title>
          <description>Telemonitoring: The Health Buddy web management system allows the patient to enter self-care data through a study provided tablet computer.
Flexible Diuretic Regimen: These patients will not be assigned to receive a flexible diuretic prescription</description>
        </group>
        <group group_id="E3">
          <title>Health Buddy Web NO/Flexible Diuretic YES</title>
          <description>Telemonitoring: These patients will not receive care with the Health Buddy Web intervention.
Flexible Diuretic Regimen: Patients will have a prescribed diuretic regimen specified by specific weight ranges.</description>
        </group>
        <group group_id="E4">
          <title>Health Buddy Web NO /Flexible Diuretic NO</title>
          <description>Telemonitoring: These patients will not be assigned to the Health Buddy Web intervention.
Flexible Diuretic Regimen: These patients will not be assigned to follow a flexible diuretic regimen.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Congestive heart failure,</sub_title>
                <description>causing death</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Hospitalization</sub_title>
                <description>Heart failure</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="13"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="14"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>ventricular tachycardia/ventricular fibrillation</sub_title>
                <description>causing death</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>cause unknown</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Occipital stroke</sub_title>
                <description>causing death</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination leading to a small number of subjects analyzed. We have enrolled a total of 51 patients when our target was to enroll 400 patients.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Todd Koelling, MD</name_or_title>
      <organization>University of Michgan Health Systems</organization>
      <phone>734-936-5265</phone>
      <email>tkoellin@med.umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

